| IgG subclasses and allotypes: from structure to effector functions G Vidarsson, G Dekkers, T Rispens Frontiers in immunology 5, 520, 2014 | 2412 | 2014 |
| Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability PJM Brouwer, TG Caniels, K van der Straten, JL Snitselaar, Y Aldon, ... Science 369 (6504), 643-650, 2020 | 1049 | 2020 |
| IgA and the IgA Fc receptor M Van Egmond, CA Damen, AB Van Spriel, G Vidarsson, E van Garderen, ... Trends in immunology 22 (4), 205-211, 2001 | 376 | 2001 |
| Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential NM Stapleton, JT Andersen, AM Stemerding, SP Bjarnarson, RC Verheul, ... Nature communications 2 (1), 599, 2011 | 266 | 2011 |
| Macrophages eliminate circulating tumor cells after monoclonal antibody therapy N Gül, L Babes, K Siegmund, R Korthouwer, M Bögels, R Braster, ... The Journal of clinical investigation 124 (2), 812-823, 2014 | 263 | 2014 |
| Decoding the human immunoglobulin G-glycan repertoire reveals a spectrum of Fc-receptor-and complement-mediated-effector activities G Dekkers, L Treffers, R Plomp, AEH Bentlage, M de Boer, ... Frontiers in immunology 8, 877, 2017 | 262 | 2017 |
| Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity MD Larsen, EL de Graaf, ME Sonneveld, HR Plomp, J Nouta, W Hoepel, ... Science 371 (6532), eabc8378, 2021 | 233 | 2021 |
| FcRn: an IgG receptor on phagocytes with a novel role in phagocytosis G Vidarsson, AM Stemerding, NM Stapleton, SE Spliethoff, H Janssen, ... Blood 108 (10), 3573-3579, 2006 | 218 | 2006 |
| A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy R Kapur, I Kustiawan, A Vestrheim, CAM Koeleman, R Visser, ... Blood, The Journal of the American Society of Hematology 123 (4), 471-480, 2014 | 197 | 2014 |
| Emerging concepts in immune thrombocytopenia M Swinkels, M Rijkers, J Voorberg, G Vidarsson, FWG Leebeek, ... Frontiers in immunology 9, 880, 2018 | 182 | 2018 |
| Affinity of human IgG subclasses to mouse Fc gamma receptors G Dekkers, AEH Bentlage, TC Stegmann, HL Howie, ... MAbs 9 (5), 767-773, 2017 | 153 | 2017 |
| Activity of human IgG and IgA subclasses in immune defense against Neisseria meningitidis serogroup B G Vidarsson, W van der Pol, JMH van den Elsen, H Vilé, M Jansen, ... The Journal of Immunology 166 (10), 6250-6256, 2001 | 149 | 2001 |
| Opsonization And Antibodies To Capsular And Cell Wall Polysaccharides Of Streptococcus Pneumoniae G Viđarsson, I Jónsdóttir, S Jónsson, H Valdimarsson Journal of Infectious Diseases 170 (3), 592-599, 1994 | 139 | 1994 |
| Regulated glycosylation patterns of IgG during alloimmune responses against human platelet antigens M Wuhrer, L Porcelijn, R Kapur, CAM Koeleman, AM Deelder, M de Haas, ... Journal of proteome research 8 (2), 450-456, 2009 | 136 | 2009 |
| Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans G Dekkers, R Plomp, CAM Koeleman, R Visser, HH Von Horsten, ... Scientific reports 6 (1), 1-12, 2016 | 133 | 2016 |
| High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote inflammation by alveolar macrophages W Hoepel, HJ Chen, CE Geyer, S Allahverdiyeva, XD Manz, SW de Taeye, ... Science translational medicine 13 (596), eabf8654, 2021 | 130 | 2021 |
| Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies L Boekel, M Steenhuis, F Hooijberg, YR Besten, ZLE van Kempen, ... The Lancet Rheumatology 3 (11), e778-e788, 2021 | 128 | 2021 |
| Divergent SARS‐CoV‐2‐specific T‐and B‐cell responses in severe but not mild COVID‐19 patients AE Oja, A Saris, CA Ghandour, NAM Kragten, BM Hogema, EJ Nossent, ... European journal of immunology 50 (12), 1998-2012, 2020 | 123 | 2020 |
| Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing M Dechant, G Vidarsson, B Stockmeyer, R Repp, MJ Glennie, ... Blood, The Journal of the American Society of Hematology 100 (13), 4574-4580, 2002 | 123 | 2002 |
| IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014; 5: 520 G Vidarsson, G Dekkers, T Rispens | 115 | 2014 |
Theo RispensSanquin Research, University of AmsterdamVerified email at sanquin.nl
